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Introduction 
 
HIV/AIDS is the leading cause of death in Sub-Saharan Africa.
1
 According to 2001 
estimates, there are 28.5 million people living with HIV in Africa, comprising more 
than 70% of the world’s HIV-infected population.1 HIV/AIDS remains one of the 
most important social and public health threats in Sub-Saharan Africa.
1
 UNAIDS 
2006 estimates that 5.5 million people are living with HIV, and almost 1,000 AIDS 
deaths occur every day in South Africa.
1
 South Africa is currently one of the most 
severely affected countries in the world.
1
  
 
The South African government has recently applied a three pronged strategy of 
information, education and communication to encourage behavioral change. Despite 
these efforts, the number of people living with HIV/AIDS continues to rise. 
  
Antiretroviral therapy (ART) is currently the only treatment available for HIV. It does 
not cure HIV infection, but reduces HIV related mortality and morbidity.
2
 Nucleoside 
reverse transcriptase inhibitors (NRTIs) inhibit virus replication by directly blocking 
chain extension during reverse transcription using nucleoside analogues as chain 
terminators; Non-nucleoside reverse transcriptase inhibitors (NNRTIs) inhibit virus 
replication by binding directly to the reverse transcriptase and prevent reverse 
transcription and Protease inhibitors (PIs) inhibit formation of mature infectious virus 
particles by blocking protease activity and thereby preventing cleavage of the gag-pol 
polyprotein. Patients with AIDS defining conditions (ADCs) take longer to regain 
their CD4 count due to the defect in the immune system. This may increase their risk 
of morbidity and mortality.
22 
 
Adherence to a medication is generally defined as the extent to which a patient takes 
medication as prescribed by their health care provider. The word “adherence” is 
preferred by many health care givers in place of “compliance”, because “compliance” 
suggests that patient is passively following doctor’s suggestions, and that the 
treatment plan is not based on a therapeutic alliance or a contract established between 
the patient and health care provider.
16
 Contrary to that, adherence is regarded as 
implying an active role of the patient in their health care. The success of Highly 
Active Antiretroviral Therapy (HAART), Tuberculosis (TB) treatment or Sexually 
Transmitted Infection (STI) treatment is dependent on close to 100% adherence to the 
treatment.  
 
Adherence to ART is the most important determinant of treatment success. Adherence 
levels of less than 95% are associated with the development of viral resistance and 
virological failure, and subsequent risk of transmission of resistant virus to others.
2
 
Patients should be treated with ART for the rest of their lives and this level of 
adherence is therefore difficult to sustain. Optimal treatment adherence has been 
closely correlated with viral suppression,
5-7
 while non adherence has contributed to 
progression to AIDS,
8
 the development of multidrug resistance and death.
9-11
 Even 
short-term non adherence (as little as 1 week) may result in a rapid increase in  
vireamia, leading to treatment failure.
12
  
 
ART is increasingly available within public and private sectors in many countries. 
The South African government started rolling out ART within the public sector in 
2004.  With a growing numbers of patients on ART, it is of utmost importance to 
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ensure high levels of adherence to have the desired effect and to avoid the risk of 
spreading drug resistant viruses. 
 
The ‘estimate of average rate of non adherence to ART range from 50% to 70% in 
many different social and cultural settings, and the risks associated with non 
adherence are dire for both the individual and society at large’.3, 4 Adherence is 
perceived as a significant barrier to the delivery of ARV therapy in sub-Saharan 
Africa.
13, 14
 Adherence to ART and TB therapy of HIV-positive patients in South 
Africa depends on several different factors, such as community participation, a 
parallel TB control programme, case identification, treatment modalities, drug supply, 
adherence support, monitoring, the clinical setting, nature of the doctor-patient 
relationship, and non-disclosure to family.
19
 The psychological and social 
consequences of HIV/AIDS also affect adherence, e.g. anxiety during HIV testing, 
difficulties adjusting to an HIV positive test result, disclosure of status, depression, 
suicidal ideation, and psychiatric illness caused directly by HIV infection (e.g. AIDS 
dementia).
20
 It must be noted that the gold standard for adherence assessment and 
intervention strategies is elusive and “one size does not fit all”.15 The experience of 
Médecins Sans Frontières (MSF) in Khayelitsha demonstrated that adherence can be 
improved with the use of special pill boxes, cards showing pills and their 
accompanying water or food needs, and technology like bleepers and SMSs.
21
 
 
This study aimed to investigate the adherence rate for patients on ART after more 
than three months, via a pill count, and to explore reasons for non adherence. The 
study was carried out at the Wellness Clinic, Tshepong Hospital, Klerksdorp, North 
West Province, South Africa.  
 
Methods 
 
The study was designed as a cross sectional survey of patients under treatment at the 
HIV Clinic in Tshepong Hospital.  
 
A sample size of 150 patients out of the 7,000 patients was considered adequate by 
the Centre for Statistical Consultation. Patients needed to be on ART for 3 months or 
more, willing to give written consent and over the age of 18 years. Every consecutive 
patient that met the inclusion criteria was invited to participate until the sample size 
was obtained over a 5 month period (November 2008 to March 2009) 
 
The best methods of adherence measurement are pill counts and electronic 
monitoring, but electronic monitoring is unavailable in our setting.
 24
 
 
The nurse conducted a pill count on each patient as they attended the clinic with their 
pill packets and patients missing more than 3 pills (<95%) in the previous month were 
categorized as non-adherent. 
 
All selected patients completed a semi structured questionnaire. Research assistants, 
who were nurses at the hospital, interviewed participants confidentially in 
consultation room, to maintain a free and unbiased environment. The questionnaire 
collected data on the patient’s demographic profile, clinical status and perceived 
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obstacles to adherence. Clinical data, such as ART commencement date, CD4 count 
and viral load, were crosschecked using the hospital records. 
 
Study data were stored in Microsoft Excel and were analyzed by Prof. Martin Kidd of 
Centre for Statistical Consultation, University of Stellenbosch and Engr. Tahir 
Choudhury of Development Bank of Southern Africa.  
 
Ethical approval was obtained from the Human Research Ethics Committee of the 
University of Stellenbosch (Project Number: N08/05/024). 
 
Results 
 
Demographic results 
 
A total of 150 participants were interviewed of whom 19 (12.7%) were non-adherent 
and 131 (87.3%) were adherent to ART. The participants’ ages ranged from 17 to 65 
years. The demography of the participants is presented in Table I. 
 
Table I: Demography of participants 
 
Category Variable Frequency 
N and (%) 
Gender Male 52 (34.7%) 
Female 98 (65.3) 
Marital status Single 97 (64.7%) 
Married 30 (20.0%) 
Widow/ Widower 17 (11.3%) 
Others 6 (4.0%) 
Country of origin South African 149 (99.3%) 
Non South African 1 (0.7%) 
Ethnicity African 150 (100%) 
Age group 18 – 34 39 (26.0%) 
35 – 65 111 (74.0%) 
Employment status Employed 32 (21.3%) 
Unemployed 52 (34.7%) 
Social grant 52 (34.7%) 
Others 14 (9.3%) 
Shift worker 
 
Yes 7 (4.7%) 
No 143 (95.3%) 
Household income < R 600 67 (44.7%) 
R 601 - R 1,000 65 (43.3%) 
R 1,001 - R 2,000 11 (7.3%) 
R 2,001 - R 4,000 5 (3.3%) 
>  R 4,000 2 (1.3%) 
Family size 1 19 (12.7%) 
2 – 3 70 (46.7%) 
4 – 5 35 (23.3) 
> 5 26 (17.3) 
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Clinical status 
 
The clinical status of the participants in terms of their CD4 counts and viral loads is 
shown in Figures 1 and 2 below. The figures confirm the benefit of ART on 
improving the CD4 count and suppression of viral load. Figure 1 and 2 show that the 
CD4 count increased from a mean of 140 at initiation to 413 (p< 0.01) at the time of 
the study; and that viral load decreased from a mean of 290,828 at initiation to a mean 
of 1,550 (p<0.01). 
 
Figure 1: Comparison of CD4 Count at initiation of ART and currently 
Initiation CD4 count Current CD4 count  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Comparison of Viral load at initiation of ART and currently 
Initiation Viral Load Current Viral Load  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II presents the medical history of the participants and techniques used for 
improving adherence. The Table shows that more than half of the participants (n=81, 
54.0%) were under treatment for longer than 24 months. Out of 150 patients 97 
(64.7%) were in WHO Stage III, oro-oesophagal candidiasis was identified as the 
main opportunistic infection (n=31, 20.7%). Psychological issues were uncommon but 
this relied on self-reports. Co-morbidity with TB was common (n=81, 49.7%).  
 
Although patients used pill boxes and treatment supporters to improve their 
adherence, the cell phone reminder was the most commonly used technique (n=65, 
35.3%). 
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Histogram of Initiation Viral load
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Table II: Medical history of participants  
 
Category Variable Frequency 
N and (%) 
Duration of medication 3-6 months 15 (10.0%) 
 6-12 months 23 (15.3%) 
 12-24 months 31 (20.7%) 
 > 24 months 81 (54.0%) 
WHO stage on initiation Stage I 14 (9.3%) 
 Stage II 18 (12.0%) 
 Stage III 97 (64.7%) 
 Stage IV 21 (14.0%) 
Opportunistic Infection Cryptococcal meningitis 5 (3.3%) 
 Oro-oesophageal candida 31 (20.7%) 
 Kaposi sarcoma 3 (2.0) 
 Others 8 (5.3%) 
 No complaint 103 (68.3%) 
Psychological Complaint Depression 7 (4.7%) 
 Anxiety 1 (0.7%) 
 Others 2 (1.4) 
 No complaint 141 (93.3) 
Other Chronic Disease Hypertension 22 (13.5%) 
(n = 163)
†
 Diabetes 3 (1.8%) 
 TB 81 (49.7%) 
 Others 6 (3.7%) 
 No complaint 51 (31.3%) 
Remembrance Pill box 40 (21.7%) 
(n = 184)
 †
 Support/ Caregiver 36 (19.6%) 
 Cell phone alarm 65 (35.3%) 
 Others 43 (23.4%) 
                                                  † Number of participants responded more than one disease condition and remembrance 
 
Reasons for non-adherence 
 
All the obstacles to adherence selected from the questionnaire and reported by the 
participants were coded and are presented in order of frequency in Table III. 
Altogether 50 different obstacles to adherence were identified. 
 
Table III: Responses as obstacles to adherence 
 Choice Count of yes % of yes 
1 Unemployed/ no income 71 47% 
2 No regular food supply at home 62 41% 
3 Side effects of medication ( nausea, vomiting) 26 17% 
4 Forgot because drunk with alcohol/took drugs 23 15% 
5 Forgot to take medication 12 8% 
6 Transport problem –clinic too far from the home 11 7% 
7 Problem with HIV disclosure to employer 11 7% 
8 Lack of social and family support 10 7% 
9 Income not sufficient 9 6% 
10 Spent time on the street looking for a job 9 6% 
11 Lack of commitment 8 5% 
12 Social engagement ( attending funeral) 8 5% 
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 Choice Count of yes % of yes 
13 Drug burden  (Use other chronic medication) 7 5% 
14 Ignored their treatment 6 4% 
15 Perception that HIV is incurable or  non-curable 5 3% 
16 Stigma/guilty feeling 4 3% 
17 Non disclosure made it difficult 3 2% 
18 Couldn’t get medication from clinic/pharmacy 3 2% 
19 Too ill to come to the clinic 2 1% 
20 
Lack of understanding about disease (language/ 
knowledge). 
2 1% 
21 
Not believing that ART can suppress virus/no 
confidence on ARVs treatment 
2 1% 
22 Work relationships 2 1% 
23 Family matters/family problems 2 1% 
24 Forgot clinic appointment 2 1% 
25 Problem with employer to adjust time schedule 2 1% 
26 Family related stress 2 1% 
27 Problem with date adjustment for clinic appointment 1 1% 
28 
Irresponsibility/lack of responsibility to take 
medication 
1 1% 
29 Bad influence from peers 1 1% 
30 Patient feels that she/he is no longer sick 1 1% 
31 Belief in tradition medication) 1 1% 
32 Bought other medication and forgot to take ARV 1 1% 
33 Depression and stress  1 1% 
34 Migration from one place to another 1 1% 
35 Forgot to set reminder on the cell phone 1 1% 
36 Family member forgot to remind them 1 1% 
37 Too many pills 1 1% 
38 Treatment is not delivered at the referral site 1 1% 
39 Emergency cases  1 1% 
40 No money to collect medication from clinic 1 1% 
41 Not eating well 1 1% 
42 Don’t think medication was needed 1 1% 
43 Difficult to adjust timing with work 1 1% 
44 Shared medication with others 1 1% 
45 Don’t want others to notice 1 1% 
46 Didn’t want to mix pills with alcohol/drugs 1 1% 
47 To many people at home to keep confidentiality  1 1% 
48 Shifting duty is a problem to carry medication at work 1 1% 
49 Children give problem 1 1% 
50 
Spend time at the shebeen 
 
1 1% 
 
These 50 obstacles were then re-categorised into 4 main themes and 13 sub-themes as 
shown in Table IV. The Table reveals that socio-economic factors are perceived to be 
the biggest obstacles, in particular financial and food related problems. Medication 
related issues and personal behaviour are the next most important issues. 
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Table IV: Categorical analysis of responses of obstacles to adherence  
Theme Count of 
yes 
n=348 
% 
Socioeconomic related factors e.g. poverty, unemployment, costs of transport etc. 
Financial problems 90 25.9 
Food problems 62 17.8 
Distance / access 12 3.1 
Employer / work related problems 17 4.4 
Patient-related factors e.g. beliefs, mental disorders, alcohol abuse etc. 
Personal behaviour 32 9.2 
Mental disorders / substances 24 6.8 
Concerns / fears 6 1.7 
Beliefs / ideas 12 3.4 
Family related 26 7.5 
Social group / friends related 1 0.3 
Health care team/health system-related factors e.g. poor service, poor relationship with health 
workers, etc. 
Health care team / health system related factors 5 1.5 
Condition-related factors e.g. symptoms, side effects, complexity of treatment, knowledge about 
meds, etc 
Medication 35 10.0 
Illness 4 1.1 
 
These 13 sub-themes were then analysed for any association with adherence or non-
adherence at the last visit as shown in Table V. None of these sub-themes showed a 
statistically significant association with adherence. 
 
Table V: Analysis of sub-themes for their association with adherence 
Theme Adherent 
 
P value 
n % 
1) Financial Yes (n=78) 70 89.74 0.35 
No (n=72) 61 84.72 
2) Food Yes (n=62) 57 91.94 0.14 
No (n=88) 74 84.09 
3) Distance/access Yes (n=11) 8 72.73 0.17 
No (n=139) 123 88.49 
4) Employer/work related Yes (n=13) 11 84.62 0.76 
No (n=137) 120 87.59 
5) Personal behaviour Yes (n=28) 25 89.29 0.72 
No (n=122) 106 86.89 
6) Mental disorders ( including 
substance abuse) 
Yes (n=22) 18 81.8 0.42 
No (n=128) 113 88.3 
8) Family related issues Yes (n=13) 10 76.92 0.27 
No (n=137) 121 88.2 
9) Social group/friends Yes (n=23) 18 78.26 0.18 
No (n=127) 113 88.98 
12) Medication Yes (n=32) 27 84.38 0.57 
No (n=118) 104 88.14 
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Discussion 
 
Main findings of the study 
 
Overall 87.3% of patients were adherent to ART during the previous month.  
 
The main challenges to adherence identified by patients were socio-economic and 
related to a lack of income and food. Medication related issues such as side effects 
and complex regimens were also important along with a range of more personal 
behavioural issues. Mental disorders, substance abuse and family-related issues were 
also identified as relevant. 
 
Discussion of results in relationship to the literature 
 
The level of non-adherence to ART among the patients of Wellness Clinic is far 
below reported levels of non-adherence that range from 50% to 70% in many different 
social and cultural settings.
3, 4
  
 
Other studies have identified health care team and health system factors as being 
important.
19
 These factors were seldom reported here; however, this may be due to the 
questionnaire design and a reluctance to report these factors when being interviewed 
by a health worker. Psychological factors have been highlighted in other studies, but 
may have been underreported here.
20 
 
 
The use of cell phones, pill boxes and social support as ways of improving adherence 
were also found to be helpful in this community and confirm the findings of MSF in 
Khayelitsha.
 21 
 
Socio-economic related factors came out as a prominent threat to adherence in the 
study and point to the interaction between poverty and adherence to medication. For 
example the struggle to survive and provide food for the family may take precedence 
over clinic attendance and a lack of income may limit the ability to travel to the clinic 
on a regular basis. Even those who had employment however struggled with a range 
of issues related to disclosure and accessing their treatment. 
 
Family relationships and social support were also identified as important and confirm 
the value of building social capital in poor communities.
25
  
 
The importance of the patients underlying beliefs, family support, current illness and 
employer related issues have also been reported in other studies..
26,27
   
 
Strength and weakness of the study 
 
The use of both open and specific questions to elicit all perceived obstacles to 
adherence is strength of the study.   
 
Main weaknesses of the study were i) non-inclusion of completely defaulted (not 
attending the clinic) patients; ii) small sample that lacked the power to test for the 
association of identified factors with adherence iii) interviewing by health workers 
may have influenced some of the responses especially related to the health services iv) 
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adherence was only measured over the previous month v) use of a self developed 
questionnaire. 
Recommendation and Conclusion 
 
The study implies that improving socio-economic conditions through job creation, 
skills development, social grants and food parcels may be beneficial to adherence.  
 
Access to treatment for those who are employed also needs to be improved and health 
services should look at ways of accommodating the needs of this group as well as 
interacting with employers to improve their understanding of the ART requirements. 
 
Attempts should be made to keep prescriptions as simple as possible and to monitor 
closely for side effects. Cell phones and other technologies should be promoted as 
ways of coping with complex and chronic regimens. 
 
Counselling should be open to discuss personal behaviour, beliefs and concerns and to 
motivate behaviour change. Counselling should also be family orientated and willing 
to assist where possible with family related issues that impair adherence. 
 
Health workers should be vigilant for mental problems, alcohol and substance abuse 
and be in a position to assist patients with these problems. 
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Used Questionnaire 
                                                                                                      STUDY NUMBER: 
 
 
 
Section 1A Demographic details. ( Ask patient ) 
1.  Study number 
 
2.  Date enrolled to study: dd____ / mm_______/ yy___________ 
 
3.  Gender: M                     F 
 
4.  Marital status: Single         Married             Widow/Widower           Others 
 
5.  What is your country origin ( country of birth) 
 
 1.  SA                   2.  Non South African 
 
6.  What is your Ethic group: 
1.  African             2. White               3.  Coloured              4.  Indian               5.  Other 
 
7.  What is your year of birth: 
 
 What is your age 
8.  What is your current employment status: 
1. Employed                                      3.  Social grant ( disability) 
 
2. Unemployed                                  4.  Other 
 
9.  Are you a shift worker?      Yes                    No 
 
10.  On average how much money do you get in your household every month: 
1. < R600.                                         4.  R2001 –R4000 
2. R601 – R1000.                              5.  > R4000  
3. R1001 – R2000. 
 
11.  What is your family size? 
Single                2-3                     4-5                          more than 5 
 
 
 
 
 
 
 
   
  
 
  
 
 
 
 
 
 
 
 
 
 
Anti - Retroviral and Adherence: Descriptive Study Questionnaire 
 
 Do not know 
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 Section 1/B Medical history ( Ask patient) 
 
1. Date initiation (ART)  dd_____mm____yy___________ 
2. Duration of medication(ART) 
1. 3-6 Months                                         3. One to two years 
2. 6-12 Months                                       4.  More than two year 
 
3.  WHO stage on initiation 
Stage I                                                    3.  Stage III                                                
Stage II                                                   4.  Stage IV 
 
4.. Initiation(With date)  
CD4: 
Viral Load: 
 
5. Current(With date)  
CD4: 
Viral Load: 
 
6. Any opportunistic  Infection 
1. Cripto meningitis                                3.  Kaposi Sarcoma 
 
2. Oro-esophageal Candida                      4. Others 
 
7. Psychological information 
1. Depression  
2. anxiety  
3. Others  
 
8. Any other chronic disease  
1. HTN                                               4.  CCM 
2. DM                                                 5.  Others 
3. TB 
 
9. How do you remember to take your pills 
 
Pill box                                                             Cell phone alarm  
 
Support/caregiver                                             Others 
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10. 
 
 
 
    11. 
What you think is/are primary obstacle(s) to take your pills regularly? 
 
Participants 
response………………………………………………………………………………………….. 
…………………………………………………………………………………………………………
………….. 
…………………………………………………………………………………………………………
……………. 
 
What do you think are other obstacle(s)? ( you can answer more than one with a tick mark) 
 
a) Side effects of medication ( nausea, vomiting)  
b) Transport problem –clinic too far from the home  
c) Lack of social and family support  
d) Drug burden  (Use other chronic medication)  
e) Lack of understanding about disease (language/ knowledge).  
 
f) Cultural diversity  ( believe on tradition medication)  
g) Perception that HIV is incurable or  non curable   
h) Short of regular food supply at home  
i) Problem with HIV disclosure ( to employer)  
j) Economic (financial) limitation of unemployment  
k)  Social engagement ( attending funeral)  
l) Change in daily routine  
m) Forgot to take medication  
n) Migration one place to other  
o) Medication was stolen  
p) Couldn’t get it from clinic/pharmacy  
q) Slept through the dose  
r) Forgot because drunk alcohol/took drugs  
s) Shared medication with others  
t) Uncertain about how to take medication  
u) Don’t think medication was needed  
v) Don’t want others to notice  
w) Didn’t want to mix pills with alcohol/drugs  
      x) Any other comments  
 
   
